Kensey Nash Announces a Manufacturing Agreement with Orteq Sports Medicine

Kensey Nash Corporation KNSY announced it has entered into a manufacturing agreement with, and made a minority equity investment in, Orteq Sports Medicine. The FDA approval of the U.S. clinical trial will trigger an additional $1 million investment in Orteq, which will, on a cumulative basis, total approximately $5 million which includes the exclusive worldwide manufacturing rights and represents an approximate 10% ownership in Orteq.